Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development
Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study
A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis
Patients’ preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis
A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia